Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest US$100 million to modernize key equipment – including 100 m³ reactors and other critical systems – enhancing reliability, enabling great…
OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, announced that it has entered into a strategic collaboration agreement with LG Chem, a leading global company that specializes in life sciences as one of its core businesses. Th…
Helix, the leading enterprise genomics company, announced a multi-year relationship with AstraZeneca, a global biopharmaceutical company. Under this agreement AstraZeneca will gain access to Helix's continuously growing, deeply phenotyped GenoSphere™ cohorts that cover a wide range of disease areas. "Our collaborati…
Bora Pharmaceuticals Co., Ltd. announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through it…
Sanyou Biopharmaceutical Co., Ltd. and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. jointly announced the official signing of a strategic cooperation agreement. This partnership will focus on the co-development of novel radiopharmaceuticals and radiodiagnostic products, aiming to integrate their respecti…
Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering solutions, announced an agreement with Catalent Pharma Solutions ("Catalent") to acquire Catalent's facility in Nottingham, UK. The acquisition,…
Ipsen and Memo Therapeutics AG announced they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG. The anticipated acquisition is focused on potravitug, which is a Phase II clinical-stage antibody against the BK polyo…
Radnostix, Inc., a leader in radioisotope production and nuclear medicine solutions, announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA System technology platform, ELLEXA Explorer software and associated intellectual property. The product line was original…
AGC Biologics enters a strategic partnership with Pyramid Pharma Services. The collaboration combines AGC Biologics’ expertise in drug substance development and manufacturing with Pyramid’s sterile fill-finish capabilities, creating a differentiated U.S.-based offering and providing developers with a fully integrated …
Nona Biosciences, a global biotechnology company advancing biologics discovery and development through innovative technology platforms, announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing technology for central nervous system (CNS) dis…
Page 10 of 43